• Sunday, October 5 Introduction to Genomic Medicine for Practitioners Optional pre-conference course

    • 11:00 AM - 5:00 PM Registration

    • 12:30 PM - 1:00 PM Matthew J. Ferber, Ph.D.
      Introduction: The Journey Begins

    • 1:00 PM - 2:00 PM The Physician's Odyssey Applying Genomics to Practice: Case Study 1 — Oncology

      • Alan H. Bryce, M.D.
      • Jennifer B. McCormick, Ph.D.
      • Brooke M. McLaughlin, CGC
      • Katherine S. Hunt, CGC
    • 2:00 PM - 3:00 PM The Physician's Odyssey Applying Genomics to Practice: Case Study 2 — Right Drug, Right Dose, Right Patient

      • Mark A. Frye, M.D.
      • Teresa M. Kruisselbrink, CGC
    • 3:00 PM - 3:20 PM Break, networking

    • 3:20 PM - 4:20 PM The Physician's Odyssey Applying Genomics to Practice: Case Study 3 — Diagnostic Odyssey

      • Eric D. Wieben, Ph.D.
      • Dusica Babovic-Vuksanovic, M.D.
      • Jennifer B. McCormick, Ph.D.
      • Kimberly A. Schahl, CGC
      • Kimberly J. Guthrie, CGC
    • 4:20 PM - 5:00 PM Matthew J. Ferber, Ph.D.
      Moving Forward: The Journey Continues

  • Monday, October 6

    • 6:30 AM - 3:00 PM Registration

    • 7:00 AM - 8:00 AM Breakfast

    • 8:00 AM - 8:15 AM Introductions, welcome, tour of conference app and polling

    • 8:15 AM - 9:00 AM Clifford A. Hudis, M.D., Memorial Sloan Kettering Cancer Center
      Disruptive Technology: What New Tools and Tests Should Mean for Patients

    • 9:00 AM - 9:45 AM Geoffrey S. Ginsburg, M.D., Ph.D., Duke University
      Realizing the Opportunities of Genomics in Health Care

    • 9:45 AM - 10:15 AM Break, networking

    • 10:15 AM - 11:00 AM Diana W. Bianchi, M.D., Tufts Medical Center
      The Impact of Noninvasive Cell-Free DNA Sequencing on Prenatal Care

    • 11:00 AM - 11:45 AM Patrick Geraghty, Florida Blue
      The Future of Health Care: 2015 and Beyond

    • 11:45 AM - 1:00 PM Lunch (Exhibit Hall)

    • 12:00 PM - 12:45 PM Barbara Nelsen, Ph.D., MBA, Nelsen Biomedical
      Startup Science: Moving From Innovation to Impact (Optional Lunchtime Session)

    • 1:00 PM - 2:30 PM Concurrent Session 1 Personalized Medicine for Hematological Cancers

    • 1:00 PM - 2:30 PM Concurrent Session 2 Next-Generation ELSI: Trends in Ethical, Legal and Social Issues Research

    • 1:00 PM - 2:30 PM Concurrent Session 3 Implementation of Drug-Gene Rules

    • 1:00 PM - 2:30 PM Concurrent Session 4 Perspectives on Reimbursement for Genomic Testing

    • 2:30 PM - 3:00 PM Break, networking

    • 3:00 PM - 3:45 PM Gloria M. Petersen, Ph.D., Mayo Clinic
      Disclosing Genomic Incidental Findings: A Researcher's Perspective

    • 3:45 PM - 4:30 PM Paul J. Hergenrother, Ph.D., University of Illinois at Urbana-Champaign
      Procaspase-3 Activation as a Personalized Anticancer Strategy: From Discovery to Clinical Trials

    • 4:40 PM - 4:45 PM Recap

    • 5:00 PM - 6:30 PM Mayo Clinic tours

      • Tour 1: Mayo Clinic Bioservices We invite you to experience the 35,000-square-foot biorepository facility, home of Mayo Clinic Bioservices, including laboratory services, sample storage and management. The 50,000-participant Mayo Clinic Biobank, a normal control collection available for use by researchers, will be highlighted in addition to our bioethics and genetic counseling services.
      • Tour 2: Medical Genome Facility See the Medical Genome Facility, a collection of five laboratories that provide deep sequencing, genotyping, gene expression, cytogenetics and proteomics services for investigators across the world. Also see the Clinical Genome Sequencing Laboratory, a state-of-the-art CLIA operation that provides deep sequencing services for clinical care.
      • Tour 3: Mayo campus tour We invite you to enjoy this 60-minute guided, walking tour of Mayo Clinic's downtown campus, which will feature stunning architecture, healing spaces and an internationally acclaimed art collection. You will learn how Mayo Clinic's mission to provide the best care to every patient every day through integrated clinical practice, education and research is reflected throughout the historical and modern facilities used by patients and staff every day.
  • Tuesday, October 7

    • 6:30 AM - 3:00 PM Registration

    • 7:00 AM - 8:00 AM Breakfast

    • 8:00 AM - 8:15 AM Introductions and welcome

    • 8:15 AM - 9:00 AM Richard Weinshilboum, M.D., Mayo Clinic
      Pharmacogenomics: Genomics and Drug Response

    • 9:00 AM - 9:45 AM Lon Cardon, Ph.D., GlaxoSmithKline
      Genomic Advances in Drug Discovery and Development

    • 9:45 AM - 10:15 AM Break, networking

    • 10:15 AM - 11:00 AM Lawrence J. Lesko, Ph.D., F.C.P., University of Florida
      Reflections on the Role of Pharmacogenomic Biomarkers in Drug Labels

    • 11:00 AM - 11:45 AM Dan M. Roden, M.D., Vanderbilt University Medical Center
      Developing Tools for Discovery and Implementation in Personalized Medicine

    • 11:45 AM - 1:00 PM Lunch (Exhibit Hall)

    • 1:00 PM - 2:30 PM Concurrent Session 1 Poster Presentations

    • 1:00 PM - 2:30 PM Concurrent Session 2 Predictive Genomics: Clinical Applications of Genomic Medicine in Healthy Adults

    • 1:00 PM - 2:30 PM Concurrent Session 3 At The Heart of Genomics: Genomics of Cardiovascular Disease

    • 1:00 PM - 2:30 PM Concurrent Session 4 Clinical Bioinformatics

    • 2:30 PM - 3:00 PM Break, networking

    • 3:00 PM - 3:45 PM Rebecca Nagy, M.S., CGC, Ohio State University College of Medicine
      The Expanding Role of the Genomic Counselor in the Personalized Medicine Era

    • 3:45 PM - 4:30 PM Matthew P. Goetz, M.D., and Judy C. Boughey, M.D., Mayo Clinic
      Breast Cancer Genome Guided Therapy (BEAUTY) Study: Development of a New Model for Individualizing Breast Cancer Treatment

    • 4:30 PM - 4:45 PM Recap

    • 5:00 PM - 7:00 PM Poster session and reception

  • Wednesday, October 8

    • 7:00 AM - 8:00 AM Breakfast

    • 8:00 AM - 8:15 AM Introductions and welcome

    • 8:15 AM - 9:00 AM Richard A. Gibbs, Ph.D., Baylor College of Medicine
      The Impact of Clinical Exome Sequencing on Genetic Research

    • 9:00 AM - 9:45 AM Munir Pirmohamed, M.B., Ch.B., Ph.D., University of Liverpool
      Improving the Safety of Drugs

    • 9:45 AM - 10:15 AM Break, networking

    • 10:15 AM - 11:00 AM Christopher L. Corless, M.D., Ph.D., Oregon Health & Science University
      Advantages and Limitations of Integrating Next-Generation Sequencing Approaches Into Clinical Cancer Diagnostics

    • 11:00 AM - 11:45 AM Peter A. Jones, Ph.D., D.Sc., Van Andel Research Institute
      The Cancer Epigenome

    • 11:45 PM - 12:00 PM Closing remarks

    Wednesday, October 8 Optional post-conference workshops

  • *Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.